NF-κB p105 processing via the ubiquitin-proteasome pathway

被引:78
作者
Sears, C
Olesen, J
Rubin, D
Finley, D
Maniatis, T
机构
[1] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA
[2] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02122 USA
关键词
D O I
10.1074/jbc.273.3.1409
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p50 subunit of NF-KB is generated by proteolytic processing of a 105-kDa precursor (p105) in yeast and mammalian cells. Here we show that yeast mutants in the ubiquitin-proteasome pathway inhibit or abolish p105 processing, Specifically, p105 processing is inhibited by a mutation in a 20 S proteasome subunit (pre1-1), by mutations in the ATPases located in the 19 S regulatory complexes of the proteasome (yta1, yta2/sug1, yta5, cim5), and by a mutation in a proteasome-associated isopeptidase (deal). A ubiquitinated intermediate of the p105 processing reaction accumulates in some of these mutants, strongly suggesting that ubiquitination is required for processing. However, none of the ubiquitin conjugating enzyme mutants tested (ubc1, -2, -3, -4/5, -6/7, -8, -9, -10, -11) had an effect on p105 processing, suggesting that more than one of these enzymes is sufficient for p105 processing. Interestingly, a mutant "N-end rule" ligase does not adversely affect p105 processing, showing that the N-end rule pathway is not involved in degrading the C-terminal region of p105. Unexpectedly, we found that a glycine-rich region of p105 that is required for p105 processing in mammalian cells is not required for processing in yeast. Thus, p105 processing in both yeast and mammalian cells requires the ubiquitin-proteasome pathway, but the mechanisms of processing, while similar, are not identical.
引用
收藏
页码:1409 / 1419
页数:11
相关论文
共 106 条
  • [11] CHANG CC, 1994, ONCOGENE, V9, P923
  • [12] MULTIPLE UBIQUITIN-CONJUGATING ENZYMES PARTICIPATE IN THE IN-VIVO DEGRADATION OF THE YEAST MAT-ALPHA-2 REPRESSOR
    CHEN, P
    JOHNSON, P
    SOMMER, T
    JENTSCH, S
    HOCHSTRASSER, M
    [J]. CELL, 1993, 74 (02) : 357 - 369
  • [13] Site-specific phosphorylation of I kappa B alpha by a novel ubiquitination-dependent protein kinase activity
    Chen, ZJ
    Parent, L
    Maniatis, T
    [J]. CELL, 1996, 84 (06) : 853 - 862
  • [14] SIGNAL-INDUCED SITE-SPECIFIC PHOSPHORYLATION TARGETS I-KAPPA-B-ALPHA TO THE UBIQUITIN-PROTEASOME PATHWAY
    CHEN, ZJ
    HAGLER, J
    PALOMBELLA, VJ
    MELANDRI, F
    SCHERER, D
    BALLARD, D
    MANIATIS, T
    [J]. GENES & DEVELOPMENT, 1995, 9 (13) : 1586 - 1597
  • [15] AUTOREGULATION OF I-KAPPA-B-ALPHA ACTIVITY
    CHIAO, PJ
    MIYAMOTO, S
    VERMA, IM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (01) : 28 - 32
  • [16] DEGRADATION OF NUCLEAR ONCOPROTEINS BY THE UBIQUITIN SYSTEM INVITRO
    CIECHANOVER, A
    DIGIUSEPPE, JA
    BERCOVICH, B
    ORIAN, A
    RICHTER, JD
    SCHWARTZ, AL
    BRODEUR, GM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (01) : 139 - 143
  • [17] CIECHANOVER A, 1982, J BIOL CHEM, V257, P2537
  • [18] COGSWELL PC, 1993, J IMMUNOL, V150, P2794
  • [19] Structure and functions of the 20S and 26S proteasomes
    Coux, O
    Tanaka, K
    Goldberg, AL
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1996, 65 : 801 - 847
  • [20] AFFINITY ISOLATION OF ACTIVE MURINE ERYTHROLEUKEMIA CELL CHROMATIN - UNIFORM-DISTRIBUTION OF UBIQUITINATED HISTONE H2A BETWEEN ACTIVE AND INACTIVE FRACTIONS
    DAWSON, BA
    HERMAN, T
    HAAS, AL
    LOUGH, J
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1991, 46 (02) : 166 - 173